BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25088352)

  • 1. Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features.
    Bruscaggin A; Monti S; Arcaini L; Ramponi A; Rattotti S; Lucioni M; Paulli M; Gaidano G; Rossi D
    Br J Haematol; 2014 Dec; 167(5):718-20. PubMed ID: 25088352
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of L265P MYD-88 mutation in a series of clonal B-cell lymphocytosis of marginal zone origin (CBL-MZ).
    Kalpadakis C; Pangalis GA; Vassilakopoulos TP; Roumelioti M; Sachanas S; Korkolopoulou P; Koulieris E; Moschogiannis M; Yiakoumis X; Tsirkinidis P; Pontikoglou C; Rondoyianni D; Papadaki HA; Panayiotidis P; Angelopoulou MK
    Hematol Oncol; 2017 Dec; 35(4):542-547. PubMed ID: 27734522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations.
    Peveling-Oberhag J; Wolters F; Döring C; Walter D; Sellmann L; Scholtysik R; Lucioni M; Schubach M; Paulli M; Biskup S; Zeuzem S; Küppers R; Hansmann ML
    BMC Cancer; 2015 Oct; 15():773. PubMed ID: 26498442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
    Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
    Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
    Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
    Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.
    Traverse-Glehen A; Bachy E; Baseggio L; Callet-Bauchu E; Gazzo S; Verney A; Hayette S; Jallades L; Ffrench M; Salles G; Coiffier B; Felman P; Berger F
    Histopathology; 2013 May; 62(6):876-93. PubMed ID: 23611359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CBL-MZ is not a single biological entity: evidence from genomic analysis and prolonged clinical follow-up.
    Parker H; McIver-Brown NR; Davis ZA; Parry M; Rose-Zerilli MJJ; Xochelli A; Gibson J; Walewska R; Strefford JC; Oscier DG
    Blood Adv; 2018 May; 2(10):1116-1119. PubMed ID: 29773550
    [No Abstract]   [Full Text] [Related]  

  • 8. Absence of MALT1 translocations in primary cutaneous marginal zone B-cell lymphoma.
    Espinet B; Gallardo F; Pujol RM; Estrach T; Servitje O; Solé F
    Haematologica; 2004 Sep; 89(9):ELT14. PubMed ID: 15377491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas.
    Remstein ED; James CD; Kurtin PJ
    Am J Pathol; 2000 Apr; 156(4):1183-8. PubMed ID: 10751343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial nodal involvement by marginal zone lymphoma. Use of IGK gene rearrangement analysis in diagnostic work-up.
    Gazzola A; Sabattini E; Mannu C; Bacci F; Sagramoso Sacchetti CA; Artioli P; Chilli L; Da Pozzo G; Piccioli M; Falini B; Pileri SA; Piccaluga PP
    Pathologica; 2011 Feb; 103(1):14-8. PubMed ID: 21837920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma.
    Novara F; Arcaini L; Merli M; Passamonti F; Zibellini S; Rizzi S; Rattotti S; Rumi E; Pascutto C; Vetro A; Astori C; Boveri E; Lucioni M; Paulli M; Zuffardi O; Lazzarino M
    Hum Pathol; 2009 Nov; 40(11):1628-37. PubMed ID: 19647853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOTCH2 mutations in marginal zone lymphoma.
    Trøen G; Wlodarska I; Warsame A; Hernández Llodrà S; De Wolf-Peeters C; Delabie J
    Haematologica; 2008 Jul; 93(7):1107-9. PubMed ID: 18508802
    [No Abstract]   [Full Text] [Related]  

  • 13. Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas.
    Mian M; Kwee I; Rinaldi A; Ponzoni M; Bhagat G; Rossi D; Arcaini L; Gascoyne RD; Mollejo M; Baldini L; Thieblemont C; Gaidano G; Zucca E; Bertoni F
    Br J Haematol; 2014 Mar; 164(6):896-9. PubMed ID: 24329863
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular characterization of a t(2;7) translocation linking CDK6 to the IGK locus in CD5(-) monoclonal B-cell lymphocytosis.
    Parker E; Macdonald JR; Wang C
    Cancer Genet; 2011 May; 204(5):260-4. PubMed ID: 21665179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and diagnostic relevance of
    Campos-Martín Y; Martínez N; Martínez-López A; Cereceda L; Casado F; Algara P; Oscier D; Menarguez FJ; García JF; Piris MA; Mollejo M
    Haematologica; 2017 Aug; 102(8):e310-e312. PubMed ID: 28522570
    [No Abstract]   [Full Text] [Related]  

  • 16. Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma.
    Grønbaek K; Ralfkiaer E; Kalla J; Skovgaard GL; Guldberg P
    J Pathol; 2003 Sep; 201(1):134-40. PubMed ID: 12950026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
    Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of splenic B-cell lymphomas in the bone marrow: a review of histopathologic, immunophenotypic, and genetic findings.
    Behdad A; Bailey NG
    Arch Pathol Lab Med; 2014 Oct; 138(10):1295-301. PubMed ID: 25268192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA losses in the frequently deleted region of 7q in SMZL.
    Ruiz-Ballesteros E; Mollejo M; Mateo M; Algara P; Martínez P; Piris MA
    Leukemia; 2007 Dec; 21(12):2547-9. PubMed ID: 17625607
    [No Abstract]   [Full Text] [Related]  

  • 20. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.
    Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M
    Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.